These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7829131)

  • 1. Overrepresentation of the V kappa IV subgroup in light chain deposition disease.
    Denoroy L; Déret S; Aucouturier P
    Immunol Lett; 1994 Sep; 42(1-2):63-6. PubMed ID: 7829131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.
    Rocca A; Khamlichi AA; Aucouturier P; Noël LH; Denoroy L; Preud'homme JL; Cogné M
    Clin Exp Immunol; 1993 Mar; 91(3):506-9. PubMed ID: 7680298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease.
    Decourt C; Cogné M; Rocca A
    Clin Exp Immunol; 1996 Nov; 106(2):357-61. PubMed ID: 8918585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel human light chain V kappa segment: serologic and structural analyses of the kappa III-like Bence Jones protein and IgG kappa light chain REE.
    Prelli F; Tummolo D; Solomon A; Frangione B
    J Immunol; 1986 Jun; 136(11):4169-73. PubMed ID: 2422275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The V kappa III subgroup light chain proteins in AL amyloidosis & autoimmune diseases.
    Alim MA; Hara Y; Kaji H; Shinoda T
    Indian J Med Res; 2001 Jul; 114():30-5. PubMed ID: 11762204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.
    Khamlichi AA; Aucouturier P; Silvain C; Bauwens M; Touchard G; Preud'homme JL; Nau F; Cogné M
    Clin Exp Immunol; 1992 Jan; 87(1):122-6. PubMed ID: 1733627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human kappa-immunoglobulin light chain.
    Eulitz M; Linke RP
    Hoppe Seylers Z Physiol Chem; 1982 Nov; 363(11):1347-58. PubMed ID: 6816713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients.
    Messiaen T; Deret S; Mougenot B; Bridoux F; Dequiedt P; Dion JJ; Makdassi R; Meeus F; Pourrat J; Touchard G; Vanhille P; Zaoui P; Aucouturier P; Ronco PM
    Medicine (Baltimore); 2000 May; 79(3):135-54. PubMed ID: 10844934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
    Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
    Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.
    Cogné M; Preud'homme JL; Bauwens M; Touchard G; Aucouturier P
    J Clin Invest; 1991 Jun; 87(6):2186-90. PubMed ID: 1904072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of monoclonal immunoglobulin light chains in urine using two-dimensional electrophoresis.
    Tichý M; Stulík J; Kovárová H; Matĕja F; Urban P
    Neoplasma; 1995; 42(1):31-4. PubMed ID: 7617072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies of three IgG kappa proteins from a patient with multiple myeloma.
    Dworsky E; Sletten K; Harboe M; Wetteland P
    Scand J Immunol; 1980; 12(4):281-7. PubMed ID: 6781064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.
    Engvig JP; Olsen KE; Gislefoss RE; Sletten K; Wahlström O; Westermark P
    Scand J Immunol; 1998 Jul; 48(1):92-8. PubMed ID: 9714416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biclonal gammopathy of kappa light chain type in a case of multiple myeloma.
    Rabhi H; Ghaffor M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():141-50. PubMed ID: 2518743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologically defined V region subgroups of human lambda light chains.
    Solomon A; Weiss DT
    J Immunol; 1987 Aug; 139(3):824-30. PubMed ID: 3110284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
    Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
    Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoglobulin free light chains in patients with monoclonal gammapathies.
    Lubimova NV; Turko TA; Votyakova OM; Kushlinskii NE
    Bull Exp Biol Med; 2012 Jun; 153(2):249-54. PubMed ID: 22816095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
    Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
    Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
    [No Abstract]   [Full Text] [Related]  

  • 19. A double monoclonal IgG1 kappa and IgG2 kappa in a single myeloma patient. Variation in clonal products and therapeutic responses.
    Goñi F; Chuba J; Buxbaum J; Frangione B
    J Immunol; 1988 Jan; 140(2):551-7. PubMed ID: 3121749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
    Turesson I; Grubb A
    Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.